Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Bio_youtuber Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1861962524704276480.png) @Bio_youtuber Biostock_Youtuber

Biostock_Youtuber posts on X about $zlab, $bbio, strong, china the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1861962524704276480/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1861962524704276480/c:line/m:interactions.svg)

- X Week XXX +378%
- X Month XXXXX -XXX%
- X Months XXXXXXXXX +740%

### Mentions: X [#](/creator/twitter::1861962524704276480/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1861962524704276480/c:line/m:posts_active.svg)

- X Month X -XX%
- X Months XX -XX%

### Followers: XXXXX [#](/creator/twitter::1861962524704276480/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1861962524704276480/c:line/m:followers.svg)

- X Week XXXXX +0.19%
- X Month XXXXX +1%
- X Months XXXXX +14%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1861962524704276480/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1861962524704276480/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[countries](/list/countries)  [finance](/list/finance) 

**Social topic influence**
[$zlab](/topic/$zlab) #3, [$bbio](/topic/$bbio) #6, [strong](/topic/strong), [china](/topic/china), [gain](/topic/gain), [$10m](/topic/$10m), [$27m](/topic/$27m), [$35m](/topic/$35m), [$43m](/topic/$43m), [the first](/topic/the-first)

**Top accounts mentioned or mentioned by**
[@biotech2k1](/creator/undefined) [@2035bio](/creator/undefined) [@phdbiotechinvesting](/creator/undefined) [@biotech2k](/creator/undefined) [@bioyoutuber](/creator/undefined) [@youtube](/creator/undefined) [@biostockinvest](/creator/undefined) [@tonyfauci2](/creator/undefined) [@codyrhodemoney](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@geneinvesting](/creator/undefined) [@ubs](/creator/undefined) [@jefferies](/creator/undefined)

**Top assets mentioned**
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
### Top Social Posts
Top posts by engagements in the last XX hours

"$ZLAB Ive built a sizable position in $ZLAB my second major holding after $BBIO. Most of Zais current valuation can be rationalized by its in-licensed assets which are high-quality. I expect the company to continue securing strong global partnerships. The DLL3-targeting ADC (ZL-1310-001) is particularly compelling: its efficacy looks roughly comparable to competitors but the safety profile appears differentiated likely due to payload linker design. Huge thanks to @Biotech2k for the consistently great insights"  
[X Link](https://x.com/Bio_youtuber/status/1985457550402416785)  2025-11-03T21:22Z 1075 followers, 1650 engagements


"$BBIO $ZLAB BMSs Cobenfy (KarXT) feels like a slower ramp so far. Zai Lab has licensed it for Greater China and plans to launch soon hopefully it will gain strong traction there. By contrast BBIOs ATTRuby though in a completely different disease area is showing a much stronger trajectory"  
[X Link](https://x.com/Bio_youtuber/status/1985529331033014435)  2025-11-04T02:07Z 1074 followers, XXX engagements


"$ZLAB $BBIO Cobenfy (KarXT) sales by BMS is showing solid growth: 2024 Q4 $10M 2025 Q1 $27M 2025 Q2 $35M 2025 Q3 $43M For a CNS drug this ramp-up in the first year is quite impressive according to AI. But it also makes you realize how remarkable BridgeBios $ATTRuby ($100M+ in early sales) really is different disease but extraordinary execution. Zai Lab holds the China rights to KarXT. Itll be interesting to see how big the market could be there once its approved"  
[X Link](https://x.com/Bio_youtuber/status/1986595138894782958)  2025-11-07T00:42Z 1075 followers, XXX engagements


"$BBIO + New I've been away from the market for a while due to a busy schedule but my investment in $BBIO has grown significantly. If the stock reaches the $8090 range I plan to sell about 2530% and hold the rest long term. In the meantime Ive been looking for my next opportunity. Over the weekend I did deeper research on a biotech stock from Biotech2ks list that fits my style limited downside risk but multi-bagger potential. I already built a small position and after this research my conviction has grown stronger. Im planning to buy more tomorrow. I believe that $BBIO and this new name will"  
[X Link](https://x.com/Bio_youtuber/status/1985148601027141944)  2025-11-03T00:54Z 1072 followers, 1883 engagements


"$ZLAB Based on the latest earnings I dont expect a sharp revenue ramp in the next XX years. For Zai Lab major re-rating will likely depend on the success of its DLL3 ADC. The data look promising the safety profile looks good and the program seems to be progressing faster than IDEAYAs"  
[X Link](https://x.com/Bio_youtuber/status/1986599495438660096)  2025-11-07T01:00Z 1076 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Bio_youtuber Avatar @Bio_youtuber Biostock_Youtuber

Biostock_Youtuber posts on X about $zlab, $bbio, strong, china the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXX +378%
  • X Month XXXXX -XXX%
  • X Months XXXXXXXXX +740%

Mentions: X #

Mentions Line Chart

  • X Month X -XX%
  • X Months XX -XX%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.19%
  • X Month XXXXX +1%
  • X Months XXXXX +14%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence countries finance

Social topic influence $zlab #3, $bbio #6, strong, china, gain, $10m, $27m, $35m, $43m, the first

Top accounts mentioned or mentioned by @biotech2k1 @2035bio @phdbiotechinvesting @biotech2k @bioyoutuber @youtube @biostockinvest @tonyfauci2 @codyrhodemoney @bowtiedbiotech @geneinvesting @ubs @jefferies

Top assets mentioned BridgeBio Pharma, Inc. Common Stock (BBIO)

Top Social Posts

Top posts by engagements in the last XX hours

"$ZLAB Ive built a sizable position in $ZLAB my second major holding after $BBIO. Most of Zais current valuation can be rationalized by its in-licensed assets which are high-quality. I expect the company to continue securing strong global partnerships. The DLL3-targeting ADC (ZL-1310-001) is particularly compelling: its efficacy looks roughly comparable to competitors but the safety profile appears differentiated likely due to payload linker design. Huge thanks to @Biotech2k for the consistently great insights"
X Link 2025-11-03T21:22Z 1075 followers, 1650 engagements

"$BBIO $ZLAB BMSs Cobenfy (KarXT) feels like a slower ramp so far. Zai Lab has licensed it for Greater China and plans to launch soon hopefully it will gain strong traction there. By contrast BBIOs ATTRuby though in a completely different disease area is showing a much stronger trajectory"
X Link 2025-11-04T02:07Z 1074 followers, XXX engagements

"$ZLAB $BBIO Cobenfy (KarXT) sales by BMS is showing solid growth: 2024 Q4 $10M 2025 Q1 $27M 2025 Q2 $35M 2025 Q3 $43M For a CNS drug this ramp-up in the first year is quite impressive according to AI. But it also makes you realize how remarkable BridgeBios $ATTRuby ($100M+ in early sales) really is different disease but extraordinary execution. Zai Lab holds the China rights to KarXT. Itll be interesting to see how big the market could be there once its approved"
X Link 2025-11-07T00:42Z 1075 followers, XXX engagements

"$BBIO + New I've been away from the market for a while due to a busy schedule but my investment in $BBIO has grown significantly. If the stock reaches the $8090 range I plan to sell about 2530% and hold the rest long term. In the meantime Ive been looking for my next opportunity. Over the weekend I did deeper research on a biotech stock from Biotech2ks list that fits my style limited downside risk but multi-bagger potential. I already built a small position and after this research my conviction has grown stronger. Im planning to buy more tomorrow. I believe that $BBIO and this new name will"
X Link 2025-11-03T00:54Z 1072 followers, 1883 engagements

"$ZLAB Based on the latest earnings I dont expect a sharp revenue ramp in the next XX years. For Zai Lab major re-rating will likely depend on the success of its DLL3 ADC. The data look promising the safety profile looks good and the program seems to be progressing faster than IDEAYAs"
X Link 2025-11-07T01:00Z 1076 followers, XXX engagements

@Bio_youtuber
/creator/twitter::Bio_youtuber